Making Statistical Sense of the Molnupiravir MOVe-OUT Clinical Trial

Oral therapies for the early treatment of COVID-19 may prevent disease progression and health system overcrowding. A new oral therapeutic named molnupiravir has been promoted as providing an approximately 50% reduction in death or the need for hospitalization. The clinical trial evaluating this drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorlund, Kristian, Sheldrick, Kyle, Meyerowitz-Katz, Gideon, Singh, Sonal, Hill, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128711/
https://www.ncbi.nlm.nih.gov/pubmed/35276667
http://dx.doi.org/10.4269/ajtmh.21-1339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128711/
https://www.ncbi.nlm.nih.gov/pubmed/35276667
http://dx.doi.org/10.4269/ajtmh.21-1339

Ejemplares similares